These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7681818)

  • 41. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
    Deb DK; Srivastava KK; Srivastava R; Srivastava BS
    Biochem Biophys Res Commun; 2000 Dec; 279(2):457-61. PubMed ID: 11118308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
    Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
    J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-Mycobacterium intracellulare complex infection induced by IFN-gamma is mediated by TNF-alpha.
    Gomez-Flores R; Tucker SD; Kansal R; Tamez-Guerra R; Mehta RT
    J Antimicrob Chemother; 1997 Feb; 39(2):189-97. PubMed ID: 9069539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlorpromazine: a drug potentially useful for treating mycobacterial infections.
    Crowle AJ; Douvas GS; May MH
    Chemotherapy; 1992; 38(6):410-9. PubMed ID: 1288966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
    Bennie CJ; To JL; Martin PA; Govendir M
    Aust Vet J; 2015; 93(1-2):40-5. PubMed ID: 25622709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro susceptibility of mycobacteria to ciprofloxacin.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1985 Nov; 16(5):575-80. PubMed ID: 2934361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibilities of Mycobacterium malmoense determined at the growth optimum pH (pH 6.0).
    Heginbothom ML; Lindholm-Levy PJ; Heifets LB
    Int J Tuberc Lung Dis; 1998 May; 2(5):430-4. PubMed ID: 9613641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1988 Dec; 22(6):857-61. PubMed ID: 3243734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.